AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?
Date: August 12, 2025
At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the session “Overcoming AI Hype for Realised ROI: Taking a Problem-Centred Approach to Enterprise Transformation” confronted this challenge head-on.
Led by Jason Housley (eClinical Solutions), the discussion pulled no punches on why stubborn timelines persist despite decades of “next-gen” innovation – from blockchain to wearables to today’s AI.
Drawing on industry survey data, real-world case studies, and his “Golden Rules” for sustainable transformation, Jason shared how organisations can cut through the buzz and focus on the problems that truly matter – delivering tangible, measurable results rather than symbolic go-lives.
Read the session summary for key takeaways – pragmatic, experience-based, and laser-focused on turning AI potential into real ROI.
Click here to read
Explore More News
AI model trained on de-identified data from 57 million people
Researchers at UCL have trained an AI model using de-identified data from 57 million . . .
Read More
ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released
The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .
Read More
ICH E6(R3) Guideline reaches Step 4 of the ICH Process
ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025.
The guideline . . .
Read More
U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties
The U.S. Food and Drug Administration has issued its first guidance on the use of . . .
Read More
ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025
As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .
Read More
Audit Trail Review DMEG Update – New Guide
The Audit Trail Review (ATR) DMEG has been hard at work putting the finishing touches on a . . .
Read More
Risk Based Quality Management DMEG Update – Recent Discussions
This year our focus has switched away from generalised RBQM to applying risk-based . . .
Read More
Regulatory Considerations DMEG Update – September 2024
The Regulatory Considerations DMEG are waiting for the release of ICH GCP E6 (R3) Annex 1 . . .
Read More
Digital Data Flow (DDF) integration through the lens of electronic Patient-Reported Outcomes (ePRO)
This article has been submitted by Leeni Joshua of ICON plc
Introduction:
Digital Data . . .
Read More
Guidance for Industry: Conducting Clinical Trials With Decentralized Elements
The Conducting Clinical Trials With Decentralized Elements final guidance has now been . . .
Read More
Welcome FGK Clinical Research as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome FGK Clinical . . .
Read More
Welcome LINK Medical as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome LINK Medical as . . .
Read More
